• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sarcoid-like reaction induced by neoadjuvant immunotherapy in Stage III non-small cell lung cancer.

作者信息

Machado Leonardo Chaves, Fonseca Eduardo Kaiser Ururahy Nunes, Oliveira Júnior Genival Viana de, Schvartsman Gustavo, Chate Rodrigo Caruso

机构信息

Department of Radiology and Imaging Diagnosis, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Department of Oncology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

出版信息

Einstein (Sao Paulo). 2024 Mar 29;22:eAI0810. doi: 10.31744/einstein_journal/2024AI0810. eCollection 2024.

DOI:10.31744/einstein_journal/2024AI0810
PMID:38567916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081020/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11081020/eaff230adda2/2317-6385-eins-22-eAI0810-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11081020/05cb3ff73bfe/2317-6385-eins-22-eAI0810-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11081020/eaff230adda2/2317-6385-eins-22-eAI0810-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11081020/05cb3ff73bfe/2317-6385-eins-22-eAI0810-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11081020/eaff230adda2/2317-6385-eins-22-eAI0810-gf02.jpg

相似文献

1
Sarcoid-like reaction induced by neoadjuvant immunotherapy in Stage III non-small cell lung cancer.新辅助免疫治疗诱导的Ⅲ期非小细胞肺癌中的结节病样反应。
Einstein (Sao Paulo). 2024 Mar 29;22:eAI0810. doi: 10.31744/einstein_journal/2024AI0810. eCollection 2024.
2
Sarcoidosis-like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response.新辅助帕博利珠单抗联合化疗后出现类肉瘤样反应，模拟 NSCLC 疾病进展，令人鼓舞地发现了病理完全缓解。
Thorac Cancer. 2021 Dec;12(24):3433-3436. doi: 10.1111/1759-7714.14228. Epub 2021 Nov 11.
3
Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.病例报告：早期肺腺癌患者接受双重免疫检查点抑制后出现类肉瘤样反应和三级淋巴结构。
Front Immunol. 2022 Jan 31;13:794217. doi: 10.3389/fimmu.2022.794217. eCollection 2022.
4
Advances in immune neoadjuvant/adjuvant therapy-related adverse events of non-small cell lung cancer.免疫新辅助/辅助治疗相关不良反应在非小细胞肺癌中的研究进展。
Asia Pac J Clin Oncol. 2022 Jun;18(3):171-176. doi: 10.1111/ajco.13378. Epub 2020 Jun 23.
5
Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations.围手术期免疫治疗在 IB-III 期非小细胞肺癌中的应用：对其原理和考虑因素的批判性评价。
Korean J Intern Med. 2023 Nov;38(6):787-796. doi: 10.3904/kjim.2023.345. Epub 2023 Nov 1.
6
[Nivolumab and sarcoid reaction in lung cancer treatment].
Rev Mal Respir. 2019 Feb;36(2):230-232. doi: 10.1016/j.rmr.2019.01.002. Epub 2019 Feb 10.
7
Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer?
J Thorac Cardiovasc Surg. 2020 Nov;160(5):1383-1384. doi: 10.1016/j.jtcvs.2020.04.050. Epub 2020 Apr 25.
8
Synchronous dilemma of sarcoid-like reaction and drastic response after PD-1 blockade administration in lung cancer.
Jpn J Clin Oncol. 2021 Jul 1;51(7):1179-1180. doi: 10.1093/jjco/hyab043.
9
[Promise of Neoadjuvant Immunotherapy in Resected Non-small Cell Lung Cancer].[新辅助免疫疗法在可切除非小细胞肺癌中的前景]
Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):55-59. doi: 10.3779/j.issn.1009-3419.2020.01.09.
10
Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy.努力改善可手术切除的非小细胞肺癌的预后：新辅助免疫治疗的前景与挑战。
Curr Oncol Rep. 2020 Aug 15;22(11):109. doi: 10.1007/s11912-020-00969-w.

本文引用的文献

1
Sarcoid-like reaction in cases treated by checkpoint inhibitors.免疫检查点抑制剂治疗后发生类肉瘤样反应。
Med Oncol. 2021 Feb 18;38(3):29. doi: 10.1007/s12032-021-01477-y.
2
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.佐剂免疫治疗中的药物诱导的类肉瘤样反应：转移的发生率增加和类似物。
Eur J Cancer. 2020 May;131:18-26. doi: 10.1016/j.ejca.2020.02.024. Epub 2020 Apr 2.
3
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor.纳武利尤单抗作为程序性死亡受体-1（PD-1）抑制剂用于肿瘤的靶向免疫治疗。
J Cancer. 2017 Feb 10;8(3):410-416. doi: 10.7150/jca.17144. eCollection 2017.
4
Pulmonary sarcoid-like granulomatosis induced by nivolumab.纳武利尤单抗诱导的肺肉瘤样肉芽肿病。
Br J Dermatol. 2017 Apr;176(4):1060-1063. doi: 10.1111/bjd.14808. Epub 2016 Dec 19.
5
Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.纳武利尤单抗诱导的晚期黑色素瘤患者类肉瘤样肉芽肿反应
Chest. 2016 May;149(5):e133-6. doi: 10.1016/j.chest.2015.10.082.